Adipose Mesenchymal Stem Cells Derived Exosomes Ameliorates KOA Cartilage Damage and Inflammation by Activation of PINK1-Mediated Mitochondrial Autophagy
- PMID: 40641285
- DOI: 10.1096/fj.202501185R
Adipose Mesenchymal Stem Cells Derived Exosomes Ameliorates KOA Cartilage Damage and Inflammation by Activation of PINK1-Mediated Mitochondrial Autophagy
Abstract
Knee osteoarthritis (KOA) is characterized by degenerative destruction of knee cartilage. Adipose tissue-derived mesenchymal stem cells (MSCs) have been widely used in the clinic to treat joint diseases, and the exosomes secreted by adipose tissue-derived MSCs (ADSC-Exos) are more stable and easier to store than stem cell therapy alone. The aim of this study was to investigate whether ADSC-Exos could reduce KOA chondrocyte damage and inflammation by activating mitochondrial autophagy. In vitro, we induced a KOA chondrocyte model with lipopolysaccharide (LPS), and after treatment with ADSC-Exos, we assessed chondrocyte damage and inflammation by using HE, Senna O solid green, and Alcian blue staining and IL-1β immunofluorescence analysis. We also labeled chondrocytes and assessed their intracellular levels of reactive oxygen species (ROS) using the DCFH-DA probe, assessed the mitochondrial membrane potential of chondrocytes using a mitochondrial membrane potential detection kit (JC-1). In vivo, we constructed a KOA rat model by anterior cruciate ligament tenotomy (ACLT) surgery, treated the knee joint with a local injection of ADSC-Exos, reconstructed the knee joint in three dimensions using micro-CT, and evaluated the pathological changes in cartilage tissues by using HE, Senna O solid green, and Alcian blue staining. The in vivo and in vitro results showed that ADSC-Exos upregulated the expression of PINK1/Parkin pathway components, promoted mitochondrial autophagy in chondrocytes, increased the mitochondrial membrane potential, protected mitochondrial function in chondrocytes, and ameliorated the degradation of the cartilage matrix and inflammation during KOA.
Keywords: PINK1/Parkin; adipose‐derived stem cells; exosome; knee osteoarthritis; mitophagy.
© 2025 Federation of American Societies for Experimental Biology.
Similar articles
-
[Mechanism of regulating PI3K-Akt signaling pathway and inhibiting chondrocyte apoptosis to improve inflammation levels in rats with knee osteoarthritis by Shenzhuo Decoction].Zhongguo Zhong Yao Za Zhi. 2025 Jun;50(12):3389-3398. doi: 10.19540/j.cnki.cjcmm.20250213.704. Zhongguo Zhong Yao Za Zhi. 2025. PMID: 40686116 Chinese.
-
Human Infrapatellar Fat Pad Mesenchymal Stem Cell-derived Extracellular Vesicles Purified by Anion Exchange Chromatography Suppress Osteoarthritis Progression in a Mouse Model.Clin Orthop Relat Res. 2024 Jul 1;482(7):1246-1262. doi: 10.1097/CORR.0000000000003067. Epub 2024 Apr 19. Clin Orthop Relat Res. 2024. PMID: 38662932 Free PMC article.
-
Injection of human umbilical cord mesenchymal stem cells exosomes for the treatment of knee osteoarthritis: from preclinical to clinical research.J Transl Med. 2025 Jun 11;23(1):641. doi: 10.1186/s12967-025-06623-y. J Transl Med. 2025. PMID: 40500748 Free PMC article. Clinical Trial.
-
Decadal analysis of efficacy and safety profiles of mesenchymal stem cells from varied sources in knee osteoarthritis patients: A systematic review and network meta-analysis.Exp Gerontol. 2024 Jul;192:112460. doi: 10.1016/j.exger.2024.112460. Epub 2024 May 20. Exp Gerontol. 2024. PMID: 38772192
-
Mesenchymal stem cell-derived exosomes for the treatment of knee osteoarthritis: a systematic review and meta-analysis based on rat model.Front Pharmacol. 2025 Jun 2;16:1588841. doi: 10.3389/fphar.2025.1588841. eCollection 2025. Front Pharmacol. 2025. PMID: 40529485 Free PMC article.
References
-
- L. Sharma, “Osteoarthritis of the Knee,” New England Journal of Medicine 384, no. 1 (2021): 51–59, https://doi.org/10.1056/NEJMcp1903768.
-
- T. Neogi and L. Colloca, “Placebo Effects in Osteoarthritis: Implications for Treatment and Drug Development,” Nature Reviews Rheumatology 19 (2023): 613–626, https://doi.org/10.1038/s41584‐023‐01021‐4.
-
- W. J. Scheuing, A. M. Reginato, M. Deeb, and K. S. Acer, “The Burden of Osteoarthritis: Is It a Rising Problem?,” Best Practice & Research. Clinical Rheumatology 37 (2023): 101836, https://doi.org/10.1016/j.berh.2023.101836.
-
- R. Geng, J. Li, C. Yu, et al., “Knee Osteoarthritis: Current Status and Research Progress in Treatment (Review),” Experimental and Therapeutic Medicine 26, no. 4 (2023): 481, https://doi.org/10.3892/etm.2023.12180.
-
- B. Kayani, L. C. Howard, M. E. Neufeld, D. S. Garbuz, and B. A. Masri, “Cannabis and Pain Control After Total Hip and Knee Arthroplasty,” Orthopedic Clinics of North America 54, no. 4 (2023): 407–415, https://doi.org/10.1016/j.ocl.2023.04.002.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources